Shockwave Medical Inc (SWAV)
327.40
-0.10
(-0.03%)
USD |
NASDAQ |
Apr 18, 16:00
327.40
0.00 (0.00%)
After-Hours: 20:00
Shockwave Medical Cash from Financing (TTM): 600.40M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 600.40M |
September 30, 2023 | 610.16M |
June 30, 2023 | -2.453M |
March 31, 2023 | 93.89M |
December 31, 2022 | 13.00M |
September 30, 2022 | 3.903M |
June 30, 2022 | 5.907M |
March 31, 2022 | 3.269M |
December 31, 2021 | -2.451M |
September 30, 2021 | -1.778M |
June 30, 2021 | -2.881M |
Date | Value |
---|---|
March 31, 2021 | 82.90M |
December 31, 2020 | 90.04M |
September 30, 2020 | 185.23M |
June 30, 2020 | 184.44M |
March 31, 2020 | 98.73M |
December 31, 2019 | 208.05M |
September 30, 2019 | 131.00M |
June 30, 2019 | 130.53M |
March 31, 2019 | 142.65M |
December 31, 2018 | 29.81M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.881M
Minimum
Jun 2021
610.16M
Maximum
Sep 2023
127.99M
Average
90.04M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 5.00M |
AtriCure Inc | -0.032M |
Masimo Corp | -57.10M |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |